ISSN 2472-0429

Advances in Cancer Prevention
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Case Report   
  • Adv Cancer Prev,
  • DOI: 10.4172/2472-0429.1000160

Malignancy Harder to Treat or Cure Cancer

Hongyu Tian*
Department of Medicine, Duke University Medical Center, Durham, USA
*Corresponding Author : Hongyu Tian, Department of Medicine, Duke University Medical Center, Durham, USA, Email: hongyutian@gmail.com

Received Date: Apr 18, 2023 / Published Date: May 18, 2023

Abstract

The prediction of response to chemotherapy at the molecular level is currently mostly based on data derived from in vitro experiments. Besides studies in patient populations and xenograft models of tumors, cell cultures are the most commonly used in vitro systems for the analysis of cellular responses to drug treatment.

Keywords: Cellular responses; Cell lines; Extracellular matrices; Angiogenesis; Anticancer therapy; Artificial manipulation

Citation: Tian H (2023) Malignancy Harder to Treat or Cure Cancer. Adv Cancer Prev 7: 160. Doi: 10.4172/2472-0429.1000160

Copyright: © 2023 Tian H. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Post Your Comment Citation
Share This Article
Recommended Conferences
Article Usage
  • Total views: 585
  • [From(publication date): 0-2023 - Oct 19, 2024]
  • Breakdown by view type
  • HTML page views: 508
  • PDF downloads: 77
Top